株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

疼痛管理薬および疼痛管理装置の世界市場

The Global Market for Pain Management Drugs and Devices

発行 BCC Research 商品コード 96391
出版日 ページ情報 英文 251 pages
即納可能
価格
本日の銀行送金レート: 1USD=113.77円で換算しております。
Back to Top
疼痛管理薬および疼痛管理装置の世界市場 The Global Market for Pain Management Drugs and Devices
出版日: 2017年08月31日 ページ情報: 英文 251 pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の疼痛管理薬・疼痛管理装置の市場規模は、2017年には361億米ドル、2022年には520億米ドルと、7.6%のCAGR (複合年間成長率) で拡大する見通しです。

当レポートでは、世界の疼痛治療薬および疼痛管理装置の市場について分析し、疾患の背景事情や技術・製品の概要、世界各国の規制整備の動き、市場の基本構造および最新情勢、将来の市場動向見通し (今後6年間分)、主な促進・抑制要因、今後の市場機会と課題、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 市場・技術の背景事情

  • 疼痛および疼痛治療の歴史
  • 疼痛の認識
  • 疼痛の種類:急性疼痛、慢性疼痛
  • 疼痛の評価:主観的/客観的評価
  • 疼痛の診断方法
  • 疼痛の治療方法
  • 人口の構造と高齢化
  • 疼痛管理処置:ステロイド、内視鏡、蛍光透視法
  • 代替的な疼痛管理手法
  • 大麻による疼痛治療の普及傾向
  • 理学的な疼痛治療手法
    • 鍼/指圧
    • 氷 (冷凍療法)
    • 関節の可動域拡張
    • 徒手整復
    • マッサージ
    • 牽引
    • 放射線治療
    • ラジオ波 (RF) 焼灼術、硬膜外内視鏡手術
    • 手術
    • ジェットバス (温熱療法)
  • 心理的な疼痛治療
    • バイオフィードバック
    • 催眠療法
    • 行動修正/オペラント条件付け
    • リラクゼーション、ストレス管理トレーニング
    • イメージ療法
    • 自己訓練
    • 心理社会学的介入 (インターベンション)
    • ストレス発散・リフレーミング
  • 補完的・代替的な疼痛管理手段:発展の動き
  • 疼痛管理サービス・機関
    • 在宅治療、ホスピス、病院、ペインクリニック、専門介護施設

第4章 業界の傾向

  • 概要
    • 過少治療の問題
    • 疼痛の治療と専門家が直面する課題
    • 処方薬モニタリングプログラム
    • 治療へのアクセス
    • マネージドケアによる疼痛管理の問題
    • FDA (米国食品医薬品局) の認証:疼痛治療薬
    • FDAの認証:疼痛管理装置
    • REMS (リスク評価・緩和戦略)
    • アセトアミノフェンとFDAの変化
    • 咳・風邪治療用のコデイン
    • NSAID (非ステロイド系抗炎症剤) と心不全・脳卒中との結びつきの拡大
    • ドラッグデリバリ・システム

第5章 疼痛治療:製品種類別

  • 概要
  • 疼痛の薬理療法
    • 疼痛治療用の処方薬
    • 市場全体
    • 麻薬性鎮痛薬
    • 非麻薬性鎮痛薬
    • 抗片頭痛薬
    • 麻酔薬
    • その他の薬剤クラス
  • 疼痛管理装置
    • 疼痛管理装置市場
    • 市場全体
    • 脊椎刺激装置
    • コンビネーション型疼痛管理装置

第6章 用途別の市場区分

  • 用途別の疼痛管理
    • 手術時の疼痛管理
    • 整形外科/筋骨格治療関連の疼痛管理
    • 線維筋痛症関連の疼痛管理
    • がん関連の疼痛管理
    • 神経障害性の疼痛管理
    • HIV/AIDS関連の疼痛管理
    • 火傷関連の疼痛管理
    • 歯科関連の疼痛管理

第7章 地域別の市場区分

  • 世界の医療指標
    • 医療支出額とGDPの分析
    • 平均入院日数
    • 世界各国の公的医療制度
  • 世界各地の市場
    • 北米
    • 欧州・中東・アフリカ諸国 (EMEA)
    • アジア太平洋地域
    • ラテンアメリカ

第8章 産業発展の動向

  • 年表:業界の主な出来事と動向
  • 医薬品のパイプライン
  • 疼痛管理装置の治験動向
  • 特許分析
    • 年度別・種類別・企業別・国別・出願人別の分析
    • 代表的な治療薬の特許情報
  • ブランド薬/ジェネリック医薬品の市場シェア
  • 疼痛研究の将来性
    • 疼痛研究:小児人口
    • 患者転帰調査
    • 主な疼痛関連の買収・アライアンス

第9章 市場機会の分析

  • 疼痛管理市場全体
    • 種類別・用途別・地域別の市場機会

第10章 企業プロファイル

付録A:用語集と情報源

BCC Researchについて

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC026F

The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Report Includes

  • An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers
  • Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Examination of product categories, use of products, and the competitive landscape
  • Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations
  • Discussion of new regulatory requirements
  • Comprehensive company profiles of major players in the industry

Report Scope

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies two general segments of pain management:

  • Pharmaceuticals.
  • Devices.

Within the pharmaceuticals segment several sub-segments are discussed in detail including:

  • Narcotic pain management.
  • Non-narcotic pain management.
  • Antimigraine treatments.
  • Anesthetics.
  • Other drugs (including CNS therapies).

The device segment covers several product lines and specifically targets the largest product segments including:

  • Electrotherapy stimulators.
  • Spine stimulators.
  • Other products (including electromagnetic therapies and other treatments).

Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.

Not covered in the report are drugs or devices that by treating the condition or disorder result in the relief of pain. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Treatments are only included for those that indicate a relief of pain symptoms associated with these conditions.

A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include:

  • Enbrel : Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
  • Celebrex : Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.

The report is also evaluated in terms of application, discussing market trends and performance for the following areas:

  • Surgical pain.
  • Orthopedic/musculoskeletal pain.
  • Migraine pain.
  • Fibromyalgia pain.
  • Cancer pain.
  • Neuropathic pain.
  • HIV/AIDS pain.
  • Dental pain.
  • General pain.

Analyst Credentials

MELISSA ELDER is a healthcare market analyst specializing in treatments, medical equipment and devices. As a research analyst for more than 20 years, she also worked in medical training and advanced medical technologies. She holds a B.S. degree in business management and is pursuing an MBA in health care management from California Coast University.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Overview
  • Summary of the Major Markets.
  • Market Trends
  • Undertreatment Issues
  • Professional Pain Treatment Issues
  • Access to Care
  • FDA Requirements for Approval of Pain Therapies
  • Drug Delivery Systems

Chapter 3: Market and Technology Background

  • History of Pain and Pain Treatment
  • The Perception of Pain
  • Types of Pain
    • Acute Pain
    • Chronic Pain
  • Assessment of Pain
    • Subjective
    • Objective
  • How Pain is Diagnosed
  • How Pain is Treated
  • Demographics and Aging Populations
    • Global Demographic Overview
    • Gender and Pain
    • Other Influences Determining How Pain is Felt Among Individuals
  • Pain Management Procedures: Steroids, Endoscopy, Fluoroscopy
  • Alternative Methods of Pain Management
  • Growing Trend in Cannabis Treatment for Pain
  • Physical Pain Treatment Modalities
    • Acupuncture/Acupressure
    • Ice (Cryotherapy)
    • Joint Mobilization
    • Manipulation
    • Massage
    • Traction
    • Radiation Therapy
    • Radio-Frequency Neuroablation, Epiduroscopy
    • Surgery
    • Whirlpool Bath (Thermotherapy)
  • Psychological Pain Therapies
    • Biofeedback
    • Hypnosis
    • Behavior Modification/Operant Conditioning
    • Relaxation and Stress Management Training
    • Imagery
    • Autogenic Training
    • Psychosocial Interventions
    • Distraction and Reframing.
  • Tracking the Development of Complementary and Alternative Pain Control Methods
  • Pain Management Services and Organizations
    • Home Care
    • Hospice
    • Hospitals
    • Pain Clinics
    • Skilled Nursing Facilities

Chapter 4: Industry Trends

  • Overview
    • Undertreatment Issues
    • Treatment of Pain and Issues Facing the Professional Segment
    • Prescription Drug Monitoring Programs
    • Access to Care
    • Managed Care Pain Management Issues
    • FDA Approval of Pain Therapies
    • FDA Approval of Pain Devices
    • Risk Evaluation and Mitigation Strategy (REMS)
    • Acetaminophen and FDA Changes
    • Codeine in Cough and Cold Medications
    • NSAIDs Linked to Increased Risk of Heart Attack or Stroke
    • Drug Delivery Systems

Chapter 5: Treating Pain: Markets by Product Type

  • Overview
  • Pharmaceutical Pain Management
    • Prescription Pain Management Products
    • Total Market
    • Narcotic Analgesics.
    • Non-narcotic Analgesics
    • Antimigraine Agents
    • Anesthetics
    • Other Drug Classes
  • Pain Management Devices
    • Pain Management Device Market
    • Total Market
    • Stimulation Therapy
    • Combination Pain Management Devices

Chapter 6: Market Breakdown by Application

  • Pain Management by Application
    • Surgical Pain Management
    • Orthopedic/Musculoskeletal Pain Management
    • Fibromyalgia Pain
    • Cancer Pain Management
    • Neuropathic Pain
    • HIV/AIDS Related Pain
    • Burn Pain
    • Dental Pain

Chapter 7: Market Breakdown by Region

  • Global Health Indicators
    • Health Expenditures and GDP Review
    • Average Length of Stay
    • Public Healthcare Systems Around the World
  • Markets by Global Region
    • North America
    • Europe, Middle East, Africa (EMEA)
    • Asia-Pacific
    • Latin America

Chapter 8: Industry Developments

  • Timeline of Significant Industry Events and Developments
  • Pharmaceutical Pipeline
  • Pain Device Clinical Trials
  • Patent Analysis
    • Patent Review by Year
    • Patent Review by Type
    • Patent Review by Company
    • Patent Review by Country
    • Patent Review by Assignee.
    • Drug Patents for Selected Therapies
  • The Brand/Generic Market Split
  • Future of Pain Research
    • Pain Research: Pediatric Populations
    • Patient Outcomes Research
    • Selected Pain-related Acquisitions and Alliances

Chapter 9: Analysis of Market Opportunities

  • Total Pain Management Market
    • Markets by Type
    • Markets by Application
    • Markets by Global Region

Chapter 10: Company Profiles

Appendix A: Terminology and Sources of Information

  • Pain Management Pharmaceutical Manufacturers and Developers
  • U.S. Pain Societies and Associations
  • International Associations and Organizations

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Market for Pain Management, by Major Segment, Through 2022 ($ Millions)
  • Table 1 Objective Signs of Pain
  • Table 2 Global Population Growth, by Select Country, 2015 and 2020 (Millions)
  • Table 3 Global Population Growth, by Age Group, Through 2050 (Millions)
  • Table 4 Global Life Expectancy at Birth, by Select Country, 1980-2020 (Years)
  • Table 5 Pain by Select Category and Gender in the Age 18+ U.S. Population,* 1997-2010 (Thousands)
  • Table 6 U.S. Medical Marijuana Programs, by State
  • Table 7 Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies, 2014 (%)
  • Table 8 Use of Complementary and Alternative Medicine Among U.S. Adults, by Type of Therapy, 2002-2015 (Thousands)
  • Table 9 Percentage of U.S. Hospice Patients, by Gender and Age Group, 2009-2014
  • Table 10 Percentage of Hospice Admissions, by Primary Diagnosis, 2009-2014 (% of Total)
  • Table 11 NHPCO Committees
  • Table 12 Definition of Pain Clinics
  • Table 13 Desirable Characteristics of Pain Clinics, by Type
  • Table 14 Registered Pain Clinics in the United States, by Top Metro Area, 2016 (Number)
  • Table 15 Registered Pain Clinics, by Country (Number)
  • Table 16 Availability of Education in Pain Management, by Select Region/Country
  • Table 17 Agency Responsible for PDMP in Each State
  • Table 18 Benefits of Prescription Monitoring Programs for Medical Boards
  • Table 19 Drugs Monitored by PDMPS, as of June 2017
  • Table 20 States with Electronic Prescription Monitoring Programs, as of June 2017
  • Table 21 Nurse Continuing Education Requirements for Pain Management, by Requiring State
  • Table 22 WHO List of Essential Medicines for Adult Pain Management
  • Table 23 Availability of Injectable Morphine, by Region/Country
  • Table 24 Availability of Oral Morphine in Hospice-Type Settings, by Region/Country
  • Table 25 FDA Analgesia/Anesthesia Drug Shortages, June 2017
  • Table 26 Parts 862-892 of 21 CFR
  • Table 27 List of Extended-Release and Long-Acting Opioid Products Subject to Opioid REMS, by Brand Name Product, May 2017
  • Table 28 List of Extended-Release and Long-Acting Opioid Products Subject to Opioid REMS, by Generic Product, May 2017
  • Table 29 List of Products Subject to the TIRF REMS Access Program, 2011-2016
  • Table 30 List of NSAIDs
  • Table 31 Advantages of Iontophoretic Drug Delivery
  • Table 32 FDA Applications/Approvals, Jan. 2010 Through Jan. 2017
  • Table 33 Global Market for Prescription Pain Management Pharmaceuticals, by Product, Through 2022 ($ Millions)
  • Table 34 Most Commonly Used General Anesthetic Agents
  • Table 35 Global Market for Pain Management Devices, by Technology Type, Through 2022 ($ Millions)
  • Table 36 Global Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 37 Global Market for Surgical Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 38 Birth Rates and Births, by Country, 2016 and 2025 (Thousands)
  • Table 39 Global Market for Orthopedic/Musculoskeletal Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 40 Global Market for Migraine/Headache Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 41 Global Market for Fibromyalgia Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 42 Cancer Pain Medication
  • Table 43 Global Market for Cancer Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 44 Global Market for Neuropathic Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 45 Global Market for HIV/AIDS Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 46 Global Market for Burn Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 47 Global Market for Dental Pain Management, Through 2022 ($ Millions)
  • Table 48 Health Expenditures as a Percentage of GDP, by Select Country, 1980-2015 (%)
  • Table 49 Average Hospital Length of Stay, by Select Country, 1970-2015 (Days)
  • Table 50 World Health Organization Ranking of Healthcare Systems, 2000
  • Table 51 Major Countries, by Region
  • Table 52 Global Market for Pain Management, by Region, Through 2022 ($ Millions)
  • Table 53 North American Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 54 EMEA Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 55 Asia-Pacific Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 56 Latin America Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 57 Select Pain Management Drug Pipelines
  • Table 58 Selected Pain Management Device Trials
  • Table 59 U.S. Patents on Pain Treatments, Issued, by Year, Jan. 2000 Through March 2017 (Number)
  • Table 60 Number of U.S. Patents on Pain Technologies, by Abstract Description
  • Table 61 U.S. Patents on Recent Pain Technologies, March 21, 2017-April 18, 2017
  • Table 62 U.S. Patent Expiration Dates for Select Pain Drugs
  • Table 63 First Time Prescription Generic Pain Management and Approvals, April 2005-June 2017
  • Table 64 Pain or Pain-related Clinical Trials, by Region, 2017
  • Table 65 Market Opportunities for Pain Management Treatments, Through 2022
  • Table 66 Global Market for Pain Management, by Major Type, Through 2022 ($ Millions)
  • Table 67 Global Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 68 Global Market for Pain Management, by Region, Through 2022 ($ Millions)
  • Table 69 Abbott Laboratories Financials, Through 2016 ($ Millions)
  • Table 70 AbbVie Financials, Through 2016 ($ Millions)
  • Table 71 Allergan Financials, Through 2016 ($ Millions)
  • Table 72 AstraZeneca Financials, Through 2016 ($ Millions)
  • Table 73 Boston Scientific Financials, Through 2016 ($ Millions)
  • Table 74 Depomed Financials, Through 2016 ($ Millions)
  • Table 75 DJO Global financials, Through 2016 ($ Millions)
  • Table 76 Eli Lilly & Co. Financials, Through 2016 ($ Millions)
  • Table 77 Endo International Financials, Through 2016 ($ Millions)
  • Table 78 GlaxoSmithKline Financials, Through 2016 ($ Millions)
  • Table 79 Grünenthal Financials, Through 2016 ($ Millions)
  • Table 80 Hisamitsu Pharmaceutical financials, Through Fiscal 2017 ($ Millions)
  • Table 81 Johnson & Johnson Financials, Through 2016 ($ Millions)
  • Table 82 Medtronic Financials, Through Fiscal Year 2016 ($ Millions)
  • Table 83 Novartis Financials, Through 2016 ($ Millions)
  • Table 84 Pfizer Financials, Through 2016 ($ Millions)
  • Table 85 Glossary of terms used in Pain Management Drug and Device Markets
  • Table 86 Pain Management Pharmaceutical Manufacturers and Developers
  • Table 87 U.S. Pain Societies and Associations
  • Table 88 International Associations and Organizations

List of Figures

  • Summary Figure: Global Market for Pain Management, by Major Segment, 2014-2022 ($ Millions)
  • Figure 1 Pain Management Techniques
  • Figure 2 Global Population, by Select Country, 2015 and 2020 (Millions)
  • Figure 3 Global Population Growth, by Age Group, 2000-2050 (Millions)
  • Figure 4 Global Life Expectancy at Birth, 1980-2020 (Years)
  • Figure 5 Pain by Select Category and Gender in the 18+ U.S. Population,* 1997-2010 (%)
  • Figure 6 Use of Complementary and Alternative Medicine Among U.S. Adults, by Type of Therapy, 2002-2015 (Thousands)
  • Figure 7 Annual Number of U.S. Hospice Patients, 2009-2014
  • Figure 8 Percentage of U.S. Hospice Patients, by Gender, 2014 (%)
  • Figure 9 Percentage of U.S. Hospice Patients, by Age Group, 2014 (%)
  • Figure10 Distribution of Causes of Mortality and Potential Need for Palliative Care (Millions)
  • Figure 11 Distribution of Narcotic Drug Consumption, by Country (All Narcotic Types) (%)
  • Figure 12 Distribution of Morphine Consumption by Region/Country, 2015 (%)
  • Figure 13 Obstacles to Availability of Opioids for Medical Needs (Number)
  • Figure 14 Global Market for Prescription Pain Management Pharmaceuticals, by Product, 2014-2022 ($ Millions)
  • Figure 15 Global Market Distribution for Narcotic Analgesics, by Ingredient*, 2017 (%)
  • Figure 16 Global Market Distribution for Non-Narcotic Analgesics, by Ingredient*, 2017 (%)
  • Figure 17 Global Market Distribution for Antimigraine Agents, by Ingredient*, 2017 (%)
  • Figure 18 Global Market Distribution for Anesthetics, by Ingredient*, 2017 (%)
  • Figure 19 Global Market for Pain Management Devices, by Technology Type, 2014-2022 ($ Millions)
  • Figure 20 Global Market for Pain Management, by Application, 2014-2022 ($ Millions)
  • Figure 21 Global Market for Surgical Pain Management, by Product Type, 2014-2022 ($ Millions)
  • Figure 22 Births, by Country, 2016 and 2025
  • Figure 23 Arthritis Impact, Global Prevalence, by Year, 2000-2050
  • Figure 24 Global Cancer Mortality by Select Country per 100,000 Population, 1960-2020
  • Figure 25 Causes of Cancer Pain
  • Figure 26 Burn Pain Management Approach
  • Figure 27 Health Expenditures as a Percentage of GDP, by Select Country, 1980-2015 (%)
  • Figure 28 Global Market for Pain Management, by Region, 2014-2022 ($ Millions)
  • Figure 29 Pain Management Drug Pipeline, by Development Status (Number)
  • Figure 30 Pain Management Drug Pipeline, by Primary Indication (Number)
  • Figure 31 Pain Management Devices in Development, by Development Status (%)
  • Figure 32 Shares of U.S. Patents on Pain Technologies, by Three-Year Date Range, Jan 2000-March 2017 (%)
  • Figure 33 Shares of U.S. Patents on Pain Technologies, by Abstract Description (%)
  • Figure 34 Patent Shares of Pain Technologies (%)
  • Figure 35 Global Market for Pain Management Pharmaceuticals, by Actual and Projected Brand vs. Generic Sales Performance, 2012-2022 ($ Millions)
  • Figure 36 Distribution of Pain-related Clinical Trials for All Ages, by Region, 2017 (%)
  • Figure 37 Distribution of Pain-related Clinical Trials for Pediatrics, by Region, 2017 (%)
  • Figure 38 Global Market for Pain Management, 2015-2022 ($ Millions)
  • Figure 39 Global Market for Pain Management, by Major Type, 2014-2022 ($ Millions)
  • Figure 40 Global Market for Pain Management, by Application, 2014-2022 ($ Millions)
  • Figure 41 Global Market for Pain Management, by Region, 2014-2022 ($ Millions)
Back to Top